| KENNESAW, Ga., Jan. 31, 2012 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that its results for the fourth quarter and year ended December 31, 2011, will be released before the opening of the market on Tuesday, February 28, 2012. MiMedx will host a live broadcast of its fourth quarter and year end conference call on Febr...continued MDXG Prosthetic Orthopedic Healthcare |
Tuesday, January 31, 2012
MiMedx Group, Inc. Announces Release Date for 2011 Fourth Quarter and Full Year Results
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment